0|chunk|SARS Coronavirus Fusion Peptide- Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice OPEN

1|chunk|autoimmune arthritis. In the present study, we provide compelling experimental in vivo evidence in support of our hypothesis. Using the SCHOOL approach and the SARS-CoV fusion peptide sequence, we rationally designed a novel immunomodulatory peptide that targets TCR. We showed that this peptide ameliorates collagen-induced arthritis in DBA/1J mice and protects against bone and cartilage damage. Incorporation of the peptide into self-assembling lipopeptide nanoparticles that mimic native human high density lipoproteins significantly increases peptide dosage efficacy. Together, our data further confirm that viral immune evasion strategies that target MIRRs can be transferred to therapeutic strategies that require similar functionalities.
1	176	183 peptide	Chemical	CHEBI_16670
1	242	249 peptide	Chemical	CHEBI_16670
1	288	295 peptide	Chemical	CHEBI_16670
1	419	426 peptide	Chemical	CHEBI_16670
1	448	459 lipopeptide	Chemical	CHEBI_46895
1	460	473 nanoparticles	Chemical	CHEBI_50803
1	511	523 lipoproteins	Chemical	CHEBI_6495
1	548	555 peptide	Chemical	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_46895
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_50803
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_6495
1	CHEBI-CHEBI	CHEBI_46895	CHEBI_50803
1	CHEBI-CHEBI	CHEBI_46895	CHEBI_6495
1	CHEBI-CHEBI	CHEBI_50803	CHEBI_6495

